C

Celltrion Pharm Inc
KOSDAQ:068760

Watchlist Manager
Celltrion Pharm Inc
KOSDAQ:068760
Watchlist
Price: 53 000 KRW 0.76% Market Closed
Market Cap: 2.2T KRW
Have any thoughts about
Celltrion Pharm Inc?
Write Note

Celltrion Pharm Inc
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Celltrion Pharm Inc
Short-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
C
Celltrion Pharm Inc
KOSDAQ:068760
Short-Term Investments
â‚©15B
CAGR 3-Years
29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Short-Term Investments
â‚©19.1B
CAGR 3-Years
-56%
CAGR 5-Years
-34%
CAGR 10-Years
-21%
SK Biopharmaceuticals Co Ltd
KRX:326030
Short-Term Investments
â‚©1.4B
CAGR 3-Years
-84%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Hanmi Science Co Ltd
KRX:008930
Short-Term Investments
â‚©3B
CAGR 3-Years
327%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Short-Term Investments
â‚©154B
CAGR 3-Years
290%
CAGR 5-Years
73%
CAGR 10-Years
11%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Short-Term Investments
â‚©16B
CAGR 3-Years
-24%
CAGR 5-Years
-16%
CAGR 10-Years
5%
No Stocks Found

Celltrion Pharm Inc
Glance View

Market Cap
2.2T KRW
Industry
Pharmaceuticals

Celltrion Pharm, Inc. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Cheongju, Chungcheongbuk-Do and currently employs 841 full-time employees. The company went IPO on 2006-02-03. The Company’s products include hepatotonics, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs, circularly system drugs, digestives and stomachic drugs, hormone disease drugs, antibiotics, nutrients, tonics, and other drugs. The company also provides ethical drugs and over-the-counter (OTC) drugs. The firm distributes its products in domestic market and overseas markets such as Philippines, Kazakhstan, Cambodia and other Southeast Asia countries.

Intrinsic Value
17 592.39 KRW
Overvaluation 67%
Intrinsic Value
Price
C

See Also

What is Celltrion Pharm Inc's Short-Term Investments?
Short-Term Investments
15B KRW

Based on the financial report for Sep 30, 2024, Celltrion Pharm Inc's Short-Term Investments amounts to 15B KRW.

What is Celltrion Pharm Inc's Short-Term Investments growth rate?
Short-Term Investments CAGR 3Y
29%

Over the last year, the Short-Term Investments growth was 20%. The average annual Short-Term Investments growth rates for Celltrion Pharm Inc have been 29% over the past three years .

Back to Top